InvestorsHub Logo
Followers 24
Posts 1198
Boards Moderated 0
Alias Born 04/23/2007

Re: SAMNOTSAMUEL post# 16607

Tuesday, 07/18/2017 11:21:24 AM

Tuesday, July 18, 2017 11:21:24 AM

Post# of 50157
Strong Buy ~(DCTH)' Selling it medication in Europe -expending -in US =FDA push on fast track 'Delcath Systems, Inc. (DCTH)' chemosaturation system. Its clinical trial include a Phase III multi-center study for patients with unresectable metastatic ocular or cutaneous melanoma exclusively or predominantly in the liver; and a multi-arm Phase II clinical trial of the Delcath chemosaturation system with melphalan in patients with primary and metastatic liver cancer, which comprise neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma. Delcath Systems, Inc. was founded in 1988-Management getting reach salaries depreciating (DCTH shares in order get control of the beard - They Know (DCTH) worth more then $16 dollars a share/

The mind is like a parachute it works best when it is open

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News